Gore Viabahn Endoprosthesis
Payments companies reported to CMS as associated with Gore Viabahn Endoprosthesis. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Gore Viabahn Endoprosthesis, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Gore Viabahn Endoprosthesis
These are the largest totals companies reported as associated with Gore Viabahn Endoprosthesis. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| David Zielske | Nashville, TN | Vascular & Interventional Radiology | $45,974.35 |
| Ellen Dillavou | Raleigh, NC | Vascular Surgery | $38,243.81 |
| Shang Loh | Philadelphia, PA | Vascular Surgery | $37,070.49 |
| Daniel Patel | Daytona Beach, FL | Nephrology (Internal Medicine) | $32,716.00 |
| Steven Abramowitz | Washington, DC | Vascular Surgery | $26,042.93 |
| William Gray | Wynnewood, PA | Interventional Cardiology | $23,199.57 |
| Nathan Liang | Pittsburgh, PA | Vascular Surgery | $20,323.52 |
| Darren Schneider | Philadelphia, PA | Vascular Surgery | $20,051.78 |
| Richard Neville | Falls Church, VA | Vascular Surgery | $15,600.00 |
| John Ross | Orangeburg, SC | Vascular Surgery | $13,565.89 |
Prescribed Gore Viabahn Endoprosthesis?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.